Effect of Dose-Dense Adjuvant Chemotherapy in HR+/HER2− Early Breast Cancer According to Luminal Subtype
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
European Journal of Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effect of Dose-Dense Adjuvant Chemotherapy in Hormone Receptor Positive/HER2-Negative Early Breast Cancer Patients According to Immunohistochemically Defined Luminal Subtype: An Exploratory Analysis of the GIM2 Trial
Eur. J. Cancer 2020 Sep 01;136(xx)43-51, B Conte, M Bruzzone, M Lambertini, F Poggio, C Bighin, E Blondeaux, M De Laurentiis, E Valle, F Cognetti, C Nisticò, S De Placido, O Garrone, T Gamucci, F Montemurro, F Puglisi, B Cardinali, P Fregatti, L Miglietta, F Boccardo, M Ceppi, L Del MastroFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.